Price:
Rs. 35,000.00
Sample Type: EDTA Blood , EDTA Bone Marrow
Fasting Not Required
Notes: L0142
Frequently Asked Questions (FAQ's):
What does the NextGen Myeloid 69 Gene Panel include?
It analyzes 69 key genes related to myeloid cancers, enabling mutation detection linked to AML, MDS, MPN, and other blood disorders.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-depth NGS sequencing technology with advanced bioinformatics for accurate and clinically relevant mutation identification.
Who should take this test?
Patients diagnosed or suspected with myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasms, or unexplained blood abnormalities.
What type of sample is required?
EDTA blood or bone marrow sample.
How long do results take at Metropolis Healthcare?
Typically 10–15 working days depending on case complexity and analysis requirements.
How can the results help in treatment decisions?
Findings guide prognosis, risk assessment, response to therapy, and suitability for targeted therapies or bone marrow transplant.
Is this test recommended for follow-up during treatment?
Yes, Metropolis Healthcare may recommend repeat testing to assess therapy response or disease relapse.
Do family members need to be tested?
In certain inherited or familial cases, Metropolis Healthcare may advise genetic evaluation of relatives based on clinician guidance